iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
2,060.2
(-0.97%)
Feb 6, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,760₹2 0%7,2000%
4500%₹265.6 0%1,800₹3.9 0%24,0750%
--1,860₹10 0%2250%
2250%₹239.6 0%1,880₹9.6 0%9000%
--1,900₹7.3 -4.57%39,8250%
4500%₹201.65 0%1,920₹10 0%32,8500%
1,1250%₹160.45 0%1,940₹12.35 0%23,4000%
2250%₹155 0%1,960₹17 0%16,4250%
2250%₹139 0%1,980₹19.75 -0.75%11,7000%
7,8750%₹80.1 0%2,000₹24 -3.42%91,5750%
1,8000%₹95.25 -1.7%2,020₹30.3 -2.57%63,2250%
15,7500%₹60.85 0.74%2,040₹39.7 2.05%39,8250%
24,5250%₹51.5 1.87%2,060₹48 -0.41%50,8500%
62,3250%₹42 1.44%2,080₹59.75 0.42%72,0000%
2,33,3250%₹33.6 -0.44%2,100₹72.4 0%84,1500%
62,7750%₹26.3 -5.05%2,120₹76.55 0%21,6000%
69,5250%₹21.65 0%2,140₹120 0%20,4750%
2,04,3000%₹17 -2.29%2,160₹99.8 0.35%13,7250%
96,9750%₹13.3 0.75%2,180₹109.45 0%6750%
3,31,2000%₹11.1 1.36%2,200₹145.25 -0.03%20,7000%
63,4500%₹8.2 -5.2%2,220₹105.45 0%00%
1,23,9750%₹6.8 1.49%2,240₹102 0%2,4750%
27,9000%₹5 0%2,260₹125.4 1.57%9000%
6,3000%₹4.2 0%2,280--
1,67,1750%₹4.2 3.7%2,300₹213.1 0%12,1500%
36,4500%₹3.3 0%2,320--
18,9000%₹2.7 0%2,340₹242.95 0%2,4750%
16,2000%₹2.3 -8%2,360₹245 0%2250%
58,2750%₹2 -4.76%2,400₹289.1 0%6,3000%
9000%₹6.3 0%2,420₹325.25 0%9000%
1,8000%₹1.25 0%2,440₹305 0%4500%
6750%₹4.8 0%2,460₹315 0%2,4750%
2,31,9750%₹1.35 -12.9%2,500₹355.4 -0.02%4,9500%
7,2000%₹2 0%2,520₹419.4 0%6750%
--2,600₹485 0%4500%
--2,640₹510 0%2250%

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.